LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 204 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $59,000 | +195.0% | 680 | +423.1% | 0.00% | +100.0% |
| Q4 2021 | $20,000 | -39.4% | 130 | -39.5% | 0.00% | 0.0% |
| Q1 2021 | $33,000 | -31.2% | 215 | -55.8% | 0.00% | -50.0% |
| Q4 2020 | $48,000 | +77.8% | 486 | +73.0% | 0.00% | -33.3% |
| Q3 2020 | $27,000 | +200.0% | 281 | +123.0% | 0.00% | -25.0% |
| Q1 2020 | $9,000 | +800.0% | 126 | +740.0% | 0.00% | – |
| Q3 2019 | $1,000 | -75.0% | 15 | -55.9% | 0.00% | -100.0% |
| Q2 2019 | $4,000 | +300.0% | 34 | +385.7% | 0.00% | – |
| Q4 2018 | $1,000 | -92.3% | 7 | -94.4% | 0.00% | -100.0% |
| Q4 2016 | $13,000 | – | 124 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |